Skip to content

Randomized Study on Effects of Uniportal VATS Versus Triportal VATS

Randomized Study on Effects of Uniportal VATS Versus Triportal VATS for the Treatment of Stage I-II NSCLC

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03240250
Enrollment
120
Registered
2017-08-07
Start date
2017-03-12
Completion date
2020-10-01
Last updated
2021-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

VATS, Pulmonary lobectomy, Uniportal, Postoperative pain, Thoracic surgery

Brief summary

For the treatment of stage I-II NSCLC, two mini-invasive techniques are mostly utilized: uni-portal and three-portal VATS. In the uniportal approach, the injury on a single intercostal space could determine a lower level of pain than the three-portal approach, allowing a better postoperative course. Few studies in Literature compare these techniques, and most of them are retrospective. The main purpose of this randomized study is to compare uni-portal VATS with three-portal VATS, in terms of postoperative pain. Secondary objectives of the study are valutations of: * respiratory and functional capacity between the two groups * operative time * number of resected lymphnodes * intra and postoperative complications, such as conversions to open surgery, amount of bleeding, prolonged air leaks, surgical site infections, pulmonary complications.

Detailed description

Randomized cohort clinical trial, prospectic, monocentric. Procedure of randomization: the day before the operation, with the Random Allocation Rule technique Arm 1: pulmonary lobectomy and lymphoadenectomy with uni-portal VATS approach Arm 2: pulmonary lobectomy and lymphoadenectomy with three-portal VATS approach Misurations Total analgesic consumption, normalized to morphine milligrams, recorded in the 7 days following the operation. The choice of cumulative analgesic consumption as parameter of primary outcome is because pain valuation with VAS is significantly affected by individual variability. Secondary outcomes: measure of postoperative pain with NRS at 2,6,12,24 hours and at 2,3,4,5,30 days from sugery. A pain score will be assigned to each patient after the total amount of NRS. Respiratory function will be valuated with spirometry after 7 and 30 days from surgery, and compared with pre-operative tests. All intraoperative parameters will be compared between the two groups: operative time (skin to skin), proportion of conversions to open surgery, number of resected lymphnodes, amount of bleeding. Postoperative complications will be analyzed: rate of prolonged air leaks, surgical site infections, cardiac rythhm disfunctions, pulmonary complications, post-thoracotomy syndrome, as well as lenght of stay at the hospital.

Interventions

PROCEDUREVATS uni-portal lobectomy and lymphoadenectomy

VATS uni-portal lobectomy and lymphoadenectomy

PROCEDUREVATS three-portal lobectomy and lymphoadenectomy

VATS three-portal lobectomy and lymphoadenectomy, Copenhagen approach

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with cT1-2N0-1M0 NSCLC, maximum diameter 5cm * ASA (American Society of Anestesiology) score 1-2-3

Exclusion criteria

* N2-N3 disease * Induction chemotherapy * Thoracic wall infiltration * Previous thoracic surgery * Important pleural adhesions * Severe COPD, asthma, interstitial lung disease - Liver, kidney or cardiac failure * Clotting disorders * Analgesic allergy * Sublobar resection, sleeve lobectomy, pneumonectomy * Chronic analgesic, oppioids or cortisonic use * Absence of informed consent

Design outcomes

Primary

MeasureTime frameDescription
Measurement of postoperative pain after uni-portal and three-portal VATS7 daysTotal analgesic consumption, normalized to morphine milligrams, recorded in the 7 days following the operation.

Secondary

MeasureTime frameDescription
Valuation of respiratory function30 daysSpirometry after 7 and 30 days from surgery, compared with pre-operative tests
Intraoperative parameters1 dayOperative time (skin to skin, minutes)
Measure of postoperative pain with NRS at 2,6,12,24 hours and at 2,3,4,5,30 days from sugery.30 daysA pain score will be assigned to each patient after the total amount of NRS
Postoperative air leakage15 daysRate of prolonged air leaks
Postoperative complications1 monthCardiac rythhm disfunctions
Intraoperative bleeding1 dayAmount of bleeding

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026